The Largest Security-Cleared Career Network for Defense and Intelligence Jobs - JOIN NOW

Homeland Security

People's Daily Online

21 COVID-19 vaccines enter clinical trials in China: official

People's Daily Online

(Xinhua) 13:49, June 07, 2021

BEIJING, June 7 (Xinhua) -- China has witnessed 21 COVID-19 vaccines enter clinical trials, an official with the National Health Commission (NHC) said Sunday.

So far, four COVID-19 vaccines have been granted conditional marketing approval and three have been authorized for emergency use within the country, according to Zeng Yixin, deputy head of the NHC.

A total of eight COVID-19 vaccines have been approved for phase III clinical trial overseas, and one messenger RNA (mRNA) COVID-19 vaccine met the ethical requirements for phase III clinical trial overseas, Zeng said.



NEWSLETTER
Join the GlobalSecurity.org mailing list